CAVADEX® reduces atherosclerosis
Heart disease and treatment explained.
RemChol reverses Heart Disease
Scientists discover treatment to reverse heart disease.
Angina dramatically reduced in 30 days. No diets or exercise.
RemChol tubes deliver 6 grams of CAVADEX® that circulates around the vascular system sucking up cholesterol and other lipids and transporting it out via the urinary system.
RemChol tubes are available now to be used from home.
Years of research to deliver a treatment for the western world’s number 1 killer, Heart Disease.
CAVADEX
The only cyclodextrin proven safe in the treatment of atherosclerosis
Our Trial Data
APRIL 2019 : CHOLREM PTY LTD LEADS THE WORLD IN RESEARCH
Angiogram: First patient has plaque reduction in just 4 weeks
CAVADEX® was administered to our first patient at our Melbourne clinic in April 2019 and within 4 weeks the plaque was reduced.
CAVADEX® circulates around the cardiovascular system removing built up cholesterol and plaque resulting in significant plaque reduction.
CAVADEX® is absorbed via intravenous application or as an enema only. If taken orally it is destroyed in the gut and has no effect.
Regular low doses of CAVADEX® can have a significant effect on plaque build up over time.
JULY 2021 : CAVADEX® BENEFIT ON LIPIDS AND LIVER
Lipid levels halved.
Dramatic reduction in plaque within 4 weeks
12 grams of CAVADEX® was administered for 26 days over a 48 day period.
STUNNING RESULTS Lipids halved, Liver improves, Plaque reduced.
Lipids
Cholesterol from 10.6 (409) down to 4.1 (159)
Triglycerides from 20.0 (1771) down to 4.6 (409)
LDL from 3.7 (143) down to 1.8 (69)
Liver
GGT from 102 down to 78
ALT from 65 down to 37
AST from 42 down to 25
Products Containing CAVADEX®
Remchol enema tubes
Remchol for home use
RemChol delivers CAVADEX® via an enema.
Each tube contains 8 grams of CAVADEX® with over 2 grams absorbed into the blood stream with every treatment.
Remchol tubes can be administered as often as one tube a day.
Available now
More Science
Science Articles
Nature
Cyclodextrin reprogrammed the cells in plaques, leading to increased transport of the dissolved cholesterol away from the plaques...
Science Daily
Cyclodextrin dissolves cholesterol crystals and reduces atherosclerotic plaques...
Huffington Post
can actually solubilize cholesterol and dissolve the plaques...
Science Daily
Soaked up cholesterol and removed it...
Norwegian University of Science and Technology
have the potential in lowering deaths caused by atherosclerosis...
CAVADEX® removes plaque and cholesterol
plaque reduced in just 4 weeks
A recent study by the University Hospital in Bonn, Germany discovered that cyclodextrin melts away cholesterol crystals (the main cause of arterial plaque that clogs arteries) and reduced existing plaque within just 4 weeks. The cyclodextrin bound to and dissolved the cholesterol crystals from the plaque of mice, leading to transport of the dissolved cholesterol away from the plaques. The same effects were seen in human plaque samples treated with cyclodextrin.
Article : Cyclodextrin promotes atherosclerosis regression via macrophage reprogrammingImprove Liver function
Another study by the University of Texas Southwestern Medical Center, Dallas, Texas, shows the treatment of Npc1-deficient mice slows cholesterol sequestration in major organs and improves liver function. This study shows that cyclodextrin is effective in mobilizing entrapped cholesterol in late stage NPC disease leading to improved liver function.
Article : Systemic administration of 2-hydroxypropyl-B-cyclodextrin to symptomatic Npc1-deficient mice slows cholesterol sequestration in the major organs and improves liver function.Cyclodextrin Publications
About Cyclodextrins
Molecular mechanism of cyclodextrin mediated cholesterol extraction
Rationale for Therapeutic Use of Lipid Transport Mediators in Renal Disease
Local TNF causes NFATc1-dependent cholesterol-mediated podocyte injury.
Systemic and renal lipids in kidney disease development and progression
Lipid biology of the podocyte--new perspectives offer new opportunities.
Renal lipid metabolism and lipotoxicity.
Cyclodextrins and Non-renal Diseases
Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming.
Neuroprotection by cyclodextrin in cell and mouse models of Alzheimer disease.
Cyclodextrins and Renal Disease
Cyclodextrin Protects Podocytes in Focal Segmental Glomerulosclerosis (FSGS)
Cyclodextrin improves renal function in experimental alport syndrome.